V. Rider

发表

Transit of normal rat uterine stromal cells through G1 phase of the cell cycle requires progesterone-growth factor interactions.

B. Kimler, S. Jones, W. Justice, 2000 .

Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus.

M. Evans, N. Abdou, V. Rider, 1998, Clinical immunology and immunopathology.

Gender Differences in Autoimmune Diseases: Immune Mechanisms and Clinical Applications

N. Abdou, V. Rider, 2010 .

Estradiol targets T cell signaling pathways in human systemic lupus.

B. Kimler, S. Svojanovsky, Peter G Smith, 2009, Clinical immunology.

Is it safe for lupus patients to take estrogen? It depends ....

N. Abdou, V. Rider, 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus.

N. Abdou, V. Rider, Nabih I. Abdou, 2001, International immunopharmacology.

Changes in the Temporal and Spatial Expression of Hβ58 During Formation and Maturation of the Chorioallantoic Placenta in the Rat1

K. Imakawa, S. Jones, V. Rider, 2000, Biology of reproduction.

Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells.

M. Evans, N. Abdou, S. Jones, 2000, Clinical immunology.

Oestrogen and progesterone control basic fibroblast growth factor mRNA in the rat uterus.

D. Carlone, V. Rider, R. Foster, 1997, The Journal of endocrinology.

WINGLESS (WNT) signaling is a progesterone target for rat uterine stromal cell proliferation

B. Kimler, V. Rider, Alex Talbott, 2016, The Journal of endocrinology.

Estradiol differentially regulates calreticulin: a potential link with abnormal T cell function in systemic lupus erythematosus?

B. Kimler, V. Rider, J. Ward, 2013, Lupus.

Progesterone and the control of uterine cell proliferation and differentiation.

V. Rider, 2002, Frontiers in bioscience : a journal and virtual library.

Molecular Mechanisms Regulating Uterine Decidualization and Implantation: Cell—Cell and Cell—Extracellular Matrix Interactions

V. Rider, 1999 .

Growth factor control of cultured rat uterine stromal cell proliferation is progesterone dependent.

O. Flieger, M. Piva, V. Rider, 1996, Biology of reproduction.

Editorial: Sex Hormones and Gender Differences in Immune Responses

V. Rider, E. Ortona, M. Pierdominici, 2019, Front. Immunol..

Alternative splicing and differential targeting of fibroblast growth factor receptor 1 in the pregnant rat uterus.

M. Cohen, D. Carlone, M. Piva, 1995, Endocrinology.

Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus.

M. Evans, N. Abdou, S. Jones, 2001, The Journal of rheumatology.

Uterine fibronectin mRNA content and localization are modulated during implantation

D. Carlone, V. Rider, N. Oliver, 1992, Developmental dynamics : an official publication of the American Association of Anatomists.

Ultrastructural correlates of meiotic maturation in mammalian oocytes.

C. Racowsky, S. Webster, V. Rider, 1990, Journal of electron microscopy technique.

The rabbit progesterone receptor and uteroglobin gene expression.

D. Lamb, P. Kima, V. Rider, 1987, Advances in experimental medicine and biology.

Patterns of intercellular connectivity in the mammalian cumulus‐oocyte complex

D. Albertini, V. Rider, Virginia Rider, 1994, Microscopy research and technique.

Evidence of H beta 58, a gene involved in mammalian placental development, in the three-toed skink, Chalcides chalcides (Squamata: Scincidae), a viviparous placentotrophic reptile.

K. Imakawa, V. Rider, R. Romagnoli, 2001, Placenta.

Progesterone-growth factor interactions in uterine stromal cells.

B. Kimler, W. Justice, V. Rider, 1998, Biology of reproduction.

Molecular and Cellular Signalling and Embryo Survival

R. Heap, F. Wooding, A. Flint, 1986 .

Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells.

K. Imakawa, Jianwen Fang, V. Rider, 2006, The Journal of endocrinology.

Isolation of Hormone Responsive Uterine Stromal Cells

V. Rider, 2006 .

Transit of rat uterine stromal cells through G1 phase of the cell cycle requires temporal and cell-specific hormone-dependent changes on cell cycle regulators.

V. Rider, E. Thomson, C. Seifert, 2003, Endocrinology.

Role of Growth Factors of Uterine and Fetal-Placental Origin During Pregnancy

M. Piva, V. Rider, 1998 .

Embryonic modulation of basic fibroblast growth factor in the rat uterus.

D. Carlone, V. Rider, D. L. Carlone, 1993, Biology of reproduction.

Sexual Dimorphism and the Immune System

N. Abdou, V. Rider, 2004 .

Anti-progesterone monoclonal antibody affects early cleavage and implantation in the mouse by mechanisms that are influenced by genotype.

R. Heap, M. Wang, V. Rider, 1987, Journal of reproduction and fertility.

Activation of uteroglobin gene expression by progesterone is modulated by uterine-specific promoter-binding proteins.

V. Rider, C. J. Peterson, 1991, Molecular endocrinology.

Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells

B. Kimler, N. Abdou, V. Rider, 2006, Lupus.

In vitro-activated human lupus T cells express normal estrogen receptor proteins which bind to the estrogen response element

M. Evans, N. Abdou, V. Rider, 2001, Lupus.

Inhibition of progesterone receptor function results in loss of basic fibroblast growth factor expression and stromal cell proliferation during uterine remodelling in the pregnant rat.

V. Rider, A. Psychoyos, 1994, The Journal of endocrinology.

Gender Bias in Human Systemic Lupus Erythematosus: A Problem of Steroid Receptor Action?

B. Fridley, Nanyan Lu, B. Kimler, 2018, Front. Immunol..

Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial.

Xiaolan Li, B. Kimler, N. Abdou, 2008, Journal of Rheumatology.

Passive immunization against progesterone inhibits endometrial sensitization in pseudopregnant mice and has antifertility effects in pregnant mice which are reversible by steroid treatment.

R. Heap, V. Rider, A. McRae, 1985, The Journal of endocrinology.

Efficacy and specificity of monoclonal antibodies to progesterone in preventing the establishment of pregnancy in the mouse.

M. Taussig, A. Butchart, R. Heap, 1988, The Journal of endocrinology.

Inhibition of pregnancy before and after implantation in rats with monoclonal antibody against progesterone.

M. Taussig, D. Hahn, R. Heap, 1988, Contraception.

Heterologous anti-progesterone monoclonal antibody arrests early embryonic development and implantation in the ferret (Mustela putorius).

R. Heap, V. Rider, 1986, Journal of Reproduction and Fertility.

Action of anti-progesterone monoclonal antibody in blocking pregnancy after postcoital administration in mice.

R. Heap, M. Wang, V. Rider, 1984, The Journal of endocrinology.

Anti-fertility effect of passive immunization against progesterone is influenced by genotype.

R. Heap, M. Wang, V. Rider, 1986, The Journal of endocrinology.

Extracellular signal–regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity

B. Kimler, N. Abdou, V. Rider, 2008, Lupus.

Differential expression of estrogen receptors in women with systemic lupus erythematosus.

Xiaolan Li, B. Kimler, N. Abdou, 2006, The Journal of rheumatology.

Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells.

M. Evans, N. Abdou, V. Rider, 1998, The Journal of rheumatology.

Stimulation of a rat uterine stromal cell line in culture reveals a molecular switch for endocrine-dependent differentiation.

M. Soares, T. Potapova, V. Rider, 2005, The Journal of endocrinology.

Isolation of hormone responsive uterine stromal cells: an in vitro model for stromal cell proliferation and differentiation.

V. Rider, 2006, Methods in Molecular Medicine.

Progesterone-dependent binding of a trans-acting factor to the uteroglobin promoter.

V. Rider, D. W. Bullock, 1988, Biochemical and biophysical research communications.